These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China. Man Y; Pan W; Lu J; Li SY; Zhang P; Guo JZ; Yu SF; Zhang B; Xiao E; Zhang C; Zuo W; Jin HJ; Chen Y; Wu B; Shi XE; Hong D; Liu X; Gao YX; Li J; Yin L; Xue QY Orthop Surg; 2016 Nov; 8(4):432-439. PubMed ID: 28032704 [TBL] [Abstract][Full Text] [Related]
4. Secondary prevention of osteoporosis following fragility fractures of the distal radius in a large health maintenance organization. Benzvi L; Gershon A; Lavi I; Wollstein R Arch Osteoporos; 2016; 11():20. PubMed ID: 27142832 [TBL] [Abstract][Full Text] [Related]
5. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK; Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809 [TBL] [Abstract][Full Text] [Related]
6. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project. Morell S; Hemmeler C; Amsler F; Gross T Swiss Med Wkly; 2017; 147():w14451. PubMed ID: 28695555 [TBL] [Abstract][Full Text] [Related]
7. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009. Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929 [TBL] [Abstract][Full Text] [Related]
8. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients? Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765 [TBL] [Abstract][Full Text] [Related]
9. Adherence to the recommended prevention strategies before and after a hip fragility fracture: what makes us go blind? Daniel A; Marques ML; Brites L; Torres C; Marques A; Pereira da Silva JA Acta Reumatol Port; 2018; 43(2):93-101. PubMed ID: 30091953 [TBL] [Abstract][Full Text] [Related]
10. Long-term persistence with anti-osteoporosis drugs after fracture. Klop C; Welsing PM; Elders PJ; Overbeek JA; Souverein PC; Burden AM; van Onzenoort HA; Leufkens HG; Bijlsma JW; de Vries F Osteoporos Int; 2015 Jun; 26(6):1831-40. PubMed ID: 25822104 [TBL] [Abstract][Full Text] [Related]
11. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain]. Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971 [TBL] [Abstract][Full Text] [Related]
12. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii. Nguyen ET; Posas-Mendoza T; Siu AM; Ahn HJ; Choi SY; Lim SY Osteoporos Int; 2018 Aug; 29(8):1827-1832. PubMed ID: 29744567 [TBL] [Abstract][Full Text] [Related]
13. Clinical effectiveness of osteoporosis treatment in older patients: A fracture liaison service-based prospective study. Mugnier B; Daumas A; Couderc AL; Mizzi B; González T; Amrani A; Lévêque P; Aymes B; Argenson JN; Villani P J Women Aging; 2019; 31(6):553-565. PubMed ID: 30295566 [TBL] [Abstract][Full Text] [Related]
14. Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: A nationwide cohort study. Wang CY; Fu SH; Huang CC; Hung CC; Yang RS; Hsiao FY Int J Clin Pract; 2018 Oct; 72(10):e13246. PubMed ID: 30144247 [TBL] [Abstract][Full Text] [Related]
15. Integrated model of secondary fracture prevention in primary care (INTERCEPT): protocol for a cluster randomised controlled multicentre trial. Wang M; Knight A; Demeshko A; Girgis CM; Bolton P; Das A; Auwyang A; Williams B; Moses D; D'Este C; Seibel MJ BMC Prim Care; 2024 Sep; 25(1):349. PubMed ID: 39342106 [TBL] [Abstract][Full Text] [Related]
16. Prevention of osteoporotic refractures in regional Australia. Davidson E; Seal A; Doyle Z; Fielding K; McGirr J Aust J Rural Health; 2017 Dec; 25(6):362-368. PubMed ID: 28618161 [TBL] [Abstract][Full Text] [Related]
17. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture]. Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575 [TBL] [Abstract][Full Text] [Related]
18. Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey. Gonnelli S; Caffarelli C; Iolascon G; Bertoldo F; Letizia Mauro G; Patti A; Nuti R Aging Clin Exp Res; 2017 Oct; 29(5):1031-1037. PubMed ID: 27943127 [TBL] [Abstract][Full Text] [Related]
19. Secondary fracture prevention in hip fracture patients requires cooperation from general practitioners. Vaculík J; Stepan JJ; Dungl P; Majerníček M; Čelko A; Džupa V Arch Osteoporos; 2017 May; 12(1):49. PubMed ID: 28812252 [TBL] [Abstract][Full Text] [Related]
20. Improvement in the primary and secondary prevention of osteoporosis by a Fracture Liaison Service: feedback from a single French center care pathway. Vrignaud A; Pelletier S; Dernis E; Moui Y; Haettich B Arch Osteoporos; 2018 Oct; 13(1):110. PubMed ID: 30324242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]